Miricor Enterprises Holdings Ltd (HK:1827)
:1827
1827 Stock Chart & Stats
HK$0.95
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.95
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.08 - HK$1.30
Previous CloseN/A
Volume40.00K
Average Volume (3M)4.67K
Market Cap
HK$376.00M
Enterprise ValueHK$282.44M
Total Cash (Recent Filing)HK$192.17M
Total Debt (Recent Filing)HK$88.76M
Price to Earnings (P/E)34.6
Beta-0.18
Next Earnings
Jun 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding400,000,000
10 Day Avg. Volume6,000
30 Day Avg. Volume4,666
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)3.17
Price to Sales (P/S)1.16
P/FCF Ratio4.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cash GenerationStrong operating and free cash flow in 2025 — with FCF nearly matching net income — indicates high earnings quality and the company’s ability to self-fund operations, capex and selective expansion of clinics or product inventory. This durable cash conversion supports reinvestment and reduces reliance on external financing, improving long-term financial flexibility.
Profitability & MarginsA gross margin above 50% and a return to operating profit in 2025 point to structural pricing power and efficient service delivery in medical aesthetics. High service and product margins allow the firm to cover fixed center costs and sustain marketing or loyalty investments, supporting durable profit generation if revenue stabilizes or grows.
Manageable LeverageImproved debt-to-equity (~0.60) and a stable equity base reduce balance-sheet risk and leave capacity to invest in clinics or absorb demand shocks. With returns on equity back positive in 2025, the capital structure is better positioned to support growth initiatives and withstand cyclical pressures in the aesthetic services market.
Bears Say
Revenue DeclineA revenue decline in 2025 signals underlying demand or volume pressure in the core service business. For a clinic and product retail model, sustained top-line contraction threatens utilization of fixed-cost clinic capacity and can erode the margin benefits; long-term growth is required to underwrite reinvestment and justify network scale.
Earnings VolatilityMaterial swings from losses in 2023–2024 to profit in 2025 highlight execution and demand variability. Such earnings volatility undermines predictability for capital allocation and investor confidence, making it harder to reliably compound equity and plan multi-year investments in clinics, staff training or product development.
Cash Flow VolatilityWhile FCF was strong in 2025, a sharp negative swing in 2022 shows cash conversion can be inconsistent. This volatility raises risk that working capital or capex demands could strain liquidity in weaker periods, limiting the durability of the current cash-strength narrative and increasing the need for contingency funding or tighter working capital controls.
Miricor Enterprises Holdings Ltd News
1827 FAQ
What was Miricor Enterprises Holdings Ltd’s price range in the past 12 months?
Miricor Enterprises Holdings Ltd lowest stock price was HK$0.08 and its highest was HK$1.30 in the past 12 months.
What is Miricor Enterprises Holdings Ltd’s market cap?
Miricor Enterprises Holdings Ltd’s market cap is HK$376.00M.
When is Miricor Enterprises Holdings Ltd’s upcoming earnings report date?
Miricor Enterprises Holdings Ltd’s upcoming earnings report date is Jun 30, 2026 which is in 82 days.
How were Miricor Enterprises Holdings Ltd’s earnings last quarter?
Miricor Enterprises Holdings Ltd released its earnings results on Nov 25, 2025. The company reported -HK$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.001.
Is Miricor Enterprises Holdings Ltd overvalued?
According to Wall Street analysts Miricor Enterprises Holdings Ltd’s price is currently Overvalued.
Does Miricor Enterprises Holdings Ltd pay dividends?
Miricor Enterprises Holdings Ltd does not currently pay dividends.
What is Miricor Enterprises Holdings Ltd’s EPS estimate?
Miricor Enterprises Holdings Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Miricor Enterprises Holdings Ltd have?
Miricor Enterprises Holdings Ltd has 400,000,000 shares outstanding.
What happened to Miricor Enterprises Holdings Ltd’s price movement after its last earnings report?
Miricor Enterprises Holdings Ltd reported an EPS of -HK$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Miricor Enterprises Holdings Ltd?
Currently, no hedge funds are holding shares in HK:1827
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Miricor Enterprises Holdings Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.36%
12-Months-Change
Fundamentals
Return on Equity
11.41%
Trailing 12-Months
Asset Growth
-2.99%
Trailing 12-Months
Company Description
Miricor Enterprises Holdings Ltd
Miricor Enterprises Holdings Limited, an investment holding company, provides medical aesthetic services in Hong Kong. It also offers a range of non-surgical medical aesthetic services, including energy-based and injection procedures. The company operates three medical aesthetic centers under the CosMax+ name. It also sells skin care products, such as cleansers, toners, serums, moisturizers, eye care products, ultraviolet protection products, and masks. Miricor Enterprises Holdings Limited was founded in 2009 and is headquartered in Causeway Bay, Hong Kong.
Technical Analysis
Water Oasis Group
―
Modern Healthcare Technology Holdings Limited
―
Perfect Medical Health Management Limited
―
Fameglow Holdings Limited
―